BD Diagnostics, a segment of Becton, Dickinson and Co., has announced it received FDA clearance to market a new MRSA test, according to a news release. BD received clearance for the BD MAX MRSA ...
Waters Corporation (NYSE:WAT) ranks among the recent spin-off companies that hedge funds are piling into. Waters Corporation (NYSE:WAT) discussed its strategy at the TD Cowen 46th Annual Health Care ...
Strong strategic fit that increases presence in multiple high-growth adjacencies and offers immediate commercial impact from Waters' proven execution model Doubles Waters' total addressable market to ...
BD (Becton, Dickinson and Co.) announced Aug. 15 a commercial collaboration under which the Franklin Lakes-based company will offer Accelerate Diagnostics Inc.’s rapid tests through its global sales ...
Longtime partners in simplifying blood sample collection and testing, BD and Babson Diagnostics are now making their miniaturized approach available to healthcare providers after years of development.
New capillary blood collection device combined with innovative sample handling and analytical technologies in clinical studies aim to make diagnostic blood testing more accessible and convenient ...
The BD COR MX/PX System integrates and automates the complete molecular laboratory workflow, from sample processing to diagnostic test result for large, high-throughput labs. – BD Becton, Dickinson ...
FRANKLIN LAKES, N.J. and AUSTIN, Texas, Dec. 17, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company (BDX)), a leading global medical technology company, and Babson Diagnostics, a science-first ...
Becton, Dickinson and CompanyBDX, also known as BD, recently announced the FDA 510(k) clearance of its Phoenix CPO detect test. This will allow hospitals to identify infections caused by carbapenemase ...
The president of BD’s life sciences division, Dave Hickey, is officially planning his retirement, with the calendar marked for July 1. Hickey has overseen BD’s portfolio of scientific research tools ...
Becton, Dickinson and Company BDX, popularly known as BD, recently announced that it has completed the previously disclosed spin-off of its Biosciences & Diagnostic business, followed by the merger of ...
Waters Corporation (NYSE: WAT) and BD (Becton, Dickinson and Company) (NYSE: BDX) today announced a definitive agreement to combine BD's Biosciences & Diagnostic Solutions business with Waters, ...